Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. Polish Acad Sci, Dept Neuropeptides, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland..
Tel Aviv Univ, Dept Anat, Sackler Sch Med, IL-69978 Tel Aviv, Israel..
Polish Acad Sci, Dept Neuropeptides, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland.;Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland..
Polish Acad Sci, Dept Neuropeptides, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland..
Show others and affiliations
2016 (English)In: Neuropharmacology, ISSN 0028-3908, E-ISSN 1873-7064, Vol. 101, p. 506-518Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Traumatic brain injury (TBI) is often a result of traffic accidents, contact sports or battlefield explosions. A mild form of traumatic brain injury (mTBI) is frequently underestimated, as the immediate physical symptoms decrease rapidly and conventional neuroimaging studies often do not show visible evidence of brain lesions. However, cognitive impairments persist for weeks, months or even years after the incident. Endogenous opioids were documented to play a role in thmodulation of mTBI pathology, whereas exogenous opioids were shown to possess neuroprotective properties. In the present study, biphalin, a dimeric enkephalin analog, improved cognitive performance in the Morris Water Maze and Novel Object Recognition tests in a mouse weight-drop model of mTBI. The effect of a single systemic injection of 10 mg/kg biphalin immediately after trauma was reversed by naltrexone, suggesting an opioid receptor-mediated mechanism. Biphalin also reduced cortical and hippocampal neurodegeneration, as shown by silver staining. Our data indicates that opioid receptor activation by biphalin may provide neuroprotection of post-traumatic neurodegeneration processes and may protect against memory impairments.

Place, publisher, year, edition, pages
2016. Vol. 101, p. 506-518
Keywords [en]
Neuroprotection, Biphalin, Traumatic brain injury, Mouse model
National Category
Neurology Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-274898DOI: 10.1016/j.neuropharm.2015.10.014ISI: 000367483800047OAI: oai:DiVA.org:uu-274898DiVA, id: diva2:899866
Available from: 2016-02-02 Created: 2016-01-26 Last updated: 2018-01-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records

Lesniak, Anna

Search in DiVA

By author/editor
Lesniak, Anna
By organisation
Department of Pharmaceutical Biosciences
In the same journal
Neuropharmacology
NeurologyPharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 267 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf